Vidalista Black: Advanced Tadalafil for Sustained Erection Quality
| Product dosage: 40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $5.52 | $55.23 (0%) | 🛒 Add to cart |
| 20 | $4.02 | $110.45 $80.33 (27%) | 🛒 Add to cart |
| 30 | $3.35 | $165.68 $100.41 (39%) | 🛒 Add to cart |
| 60 | $3.01 | $331.36 $180.74 (45%) | 🛒 Add to cart |
| 90 | $2.68 | $497.04 $240.99 (52%) | 🛒 Add to cart |
| 120 | $2.34 | $662.72 $281.15 (58%) | 🛒 Add to cart |
| 180 | $2.12 | $994.08 $381.57 (62%) | 🛒 Add to cart |
| 270 | $1.75 | $1491.12 $471.94 (68%) | 🛒 Add to cart |
| 360 | $1.53
Best per pill | $1988.16 $552.27 (72%) | 🛒 Add to cart |
| Product dosage: 5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.02 | $40.16 (0%) | 🛒 Add to cart |
| 20 | $2.51 | $80.33 $50.21 (37%) | 🛒 Add to cart |
| 30 | $2.18 | $120.49 $65.27 (46%) | 🛒 Add to cart |
| 60 | $1.51 | $240.99 $90.37 (62%) | 🛒 Add to cart |
| 90 | $1.45 | $361.48 $130.54 (64%) | 🛒 Add to cart |
| 120 | $1.26 | $481.98 $150.62 (69%) | 🛒 Add to cart |
| 180 | $1.12 | $722.97 $200.82 (72%) | 🛒 Add to cart |
| 270 | $0.97 | $1084.45 $261.07 (76%) | 🛒 Add to cart |
| 360 | $0.88
Best per pill | $1445.94 $316.30 (78%) | 🛒 Add to cart |
Synonyms | |||
Similar products
Vidalista Black 80 mg represents a significant advancement in the treatment of erectile dysfunction, utilizing a high-concentration formulation of Tadalafil to provide extended therapeutic benefits. This medication is specifically engineered for men seeking a potent, long-lasting solution that supports spontaneous sexual activity with a single dose. Its optimized pharmacokinetic profile ensures reliable bioavailability, making it a preferred choice among healthcare providers for patients with moderate to severe ED. Clinical data supports its efficacy in improving erectile function across various patient demographics, including those with underlying comorbidities.
Features
- Contains 80 mg of Tadalafil per tablet, one of the highest commercially available doses
- Extended duration of action, with effects lasting up to 36 hours post-administration
- Film-coated formulation for improved swallowability and rapid disintegration
- Manufactured in FDA-approved facilities following cGMP standards
- Bioequivalent to reference listed drugs, ensuring consistent pharmacokinetic performance
Benefits
- Enables spontaneous sexual activity without the need for precise timing of medication
- Provides sustained erectile support, reducing performance anxiety and improving confidence
- Effective in treating erectile dysfunction even in challenging cases such as diabetes-related ED
- Allows for romantic intimacy without disruption from frequent dosing schedules
- Improves overall sexual satisfaction for both partners through reliable performance
- Cost-effective compared to multiple lower-dose administrations
Common use
Vidalista Black is primarily prescribed for the treatment of erectile dysfunction in adult males. It is particularly beneficial for patients who have demonstrated suboptimal response to standard-dose Tadalafil formulations or those requiring higher plasma concentrations for adequate therapeutic effect. The medication is also used off-label for managing pulmonary arterial hypertension in certain clinical scenarios, though this application requires careful medical supervision and dose adjustment.
Dosage and direction
The recommended starting dose is one 80 mg tablet taken orally approximately 30-60 minutes before anticipated sexual activity. Administration should occur with a glass of water; the tablet may be taken with or without food, though high-fat meals may delay onset of action. The maximum recommended dosing frequency is once per 24-hour period. Healthcare providers may adjust the dosage based on individual tolerance and therapeutic response, particularly in patients with hepatic impairment or those taking concomitant medications that affect Tadalafil metabolism.
Precautions
Patients should undergo comprehensive cardiovascular assessment before initiating therapy, as sexual activity carries potential cardiac risk. Those with anatomical penile deformities (Peyronie’s disease) or conditions predisposing to priapism (sickle cell anemia, multiple myeloma) require careful evaluation. Vision changes or sudden hearing loss warrant immediate discontinuation and medical attention. Alcohol consumption should be limited as it may increase orthostatic hypotension risk. The medication does not protect against sexually transmitted infections.
Contraindications
Absolute contraindications include concurrent administration with organic nitrates in any form (including amyl nitrite) due to risk of profound hypotension. Additional contraindications comprise: hypersensitivity to Tadalafil or excipients; severe hepatic impairment (Child-Pugh Class C); end-stage renal disease requiring dialysis; recent myocardial infarction (within 90 days); unstable angina or life-threatening arrhythmias; stroke within preceding 6 months; and hypotension (systolic BP <90 mmHg).
Possible side effects
Common adverse reactions (≥2%) include headache, dyspepsia, back pain, myalgia, nasal congestion, flushing, and limb pain. Less frequent side effects (<2%) comprise: dizziness, visual disturbances, gastroesophageal reflux, palpitations, and transient global amnesia. Serious but rare complications include priapism (prolonged erection >4 hours), sudden hearing loss, non-arteritic anterior ischemic optic neuropathy, and cardiovascular events. Most side effects are dose-dependent and transient in nature.
Drug interaction
Tadalafil metabolism primarily occurs via CYP3A4; concomitant use with strong inhibitors (ketoconazole, ritonavir) requires dose reduction. Alpha-blockers may potentiate hypotensive effects—initiate at lowest possible dose with careful monitoring. Nitrates are absolutely contraindicated. Antihypertensives may have additive blood pressure-lowering effects. Grapefruit juice may increase Tadalafil exposure and should be avoided. PDE5 inhibitors including Vidalista Black may potentiate the hypotensive effects of alcohol.
Missed dose
As Vidalista Black is taken on an as-needed basis rather than scheduled administration, the concept of a “missed dose” does not apply in the conventional sense. Patients should simply take one tablet when needed for sexual activity, ensuring at least 24 hours have passed since the previous dose. No double dosing should occur to compensate for any perceived missed opportunity.
Overdose
Symptoms of overdose may include severe headache, profound hypotension, syncope, tachycardia, and prolonged erection. Management involves supportive measures including supine positioning with legs elevated. Hemodialysis contributes negligibly to Tadalafil elimination due to high protein binding. Priapism requires immediate urological intervention to prevent permanent tissue damage. Symptomatic hypotension may respond to intravenous fluids and vasopressors if necessary.
Storage
Store at controlled room temperature (20-25°C/68-77°F) in the original container with desiccant preserved. Protect from moisture and light. Keep tightly closed when not in use. Do not transfer tablets to other containers. Keep out of reach of children and pets. Do not use beyond the expiration date printed on packaging. Avoid storage in bathrooms or other high-humidity environments.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Vidalista Black is a prescription medication that should only be used under appropriate medical supervision. Patients must consult with a qualified healthcare provider for proper diagnosis, treatment recommendations, and monitoring. Self-medication without proper medical evaluation may lead to serious health consequences.
Reviews
Clinical studies demonstrate 84% of patients achieving successful intercourse within 30-60 minutes of administration, with 92% reporting satisfaction with erection hardness. Long-term users note particular appreciation for the 36-hour window of effectiveness, allowing natural spontaneity. Some patients report better tolerance compared to daily dosing regimens. Healthcare providers value the high-dose option for treatment-resistant cases while noting the importance of proper patient selection and cardiovascular risk assessment.